Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Sodium chloride + sodium lactate + dextrose monohydrate + potassium chloride + calcium chloride** is a sterile hypertonic crystalloid intravenous fluid and electrolyte replacement solution, marketed as **Lactated Ringer's and 5% Dextrose Injection**. It supplies water, sodium, chloride, potassium, calcium, lactate, and dextrose for extracellular-volume and electrolyte replacement with modest caloric support. Sodium lactate is metabolized to carbon dioxide and water with consumption of hydrogen ions, producing a metabolic alkalinizing effect; dextrose provides carbohydrate calories and supports blood glucose. The solution is indicated in adults and pediatric patients as a source of water, electrolytes, and calories or as an alkalinizing agent. Each 100 mL contains dextrose hydrous 5 g, sodium chloride 600 mg, sodium lactate anhydrous 310 mg, potassium chloride 30 mg, and calcium chloride dihydrate 20 mg; it has an approximate osmolarity of 525 mOsmol/L and pH 4.0 to 6.5. ([dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6acc9f96-7088-45a7-b48f-1a861e3467ab))
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on sodium chloride + sodium lactate + dextrose monohydrate + potassium chloride + calcium chloride.